Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status

Therapy-related myelodysplastic syndrome is a long-term complication of cancer treatment in patients receiving cytotoxic therapy, characterized by high-risk genetics and poor outcomes. Allogeneic hematopoietic cell transplantation is the only potential cure for this disease, but the prognostic impac...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Haematologica
Main Authors: Aldoss, Ibrahim, Pham, Anh, Li, Sierra Min, Gendzekhadze, Ketevan, Afkhami, Michelle, Telatar, Milhan, Hong, Hao, Padeganeh, Abbas, Bedell, Victoria, Cao, Thai, Khaled, Samer K, Malki, Monzr M Al, Salhotra, Amandeep, Ali, Haris, Aribi, Ahmed, Palmer, Joycelynne, Aoun, Patricia, Spielberger, Ricardo, Stein, Anthony S, Snyder, David, O’Donnell, Margaret R, Murata-Collins, Joyce, Senitzer, David, Weisenburger, Dennis, Forman, Stephen J, Pullarkat, Vinod, Marcucci, Guido, Pillai, Raju, Nakamura, Ryotaro
פורמט: Artigo
שפה:Inglês
יצא לאור: Ferrata Storti Foundation 2017
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5709102/
https://ncbi.nlm.nih.gov/pubmed/28971906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.172544
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים